Company news
Nutriband Inc. news in 2021
Nutriband Inc.'s news releases, calls and decks from 2021, newest first.
Nutriband Inc. Announces $1 Million Share Repurchase Authorization
December 28, 2021
Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services
December 20, 2021
Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary
December 12, 2021
Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021
December 2, 2021
Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl
November 15, 2021
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M
October 21, 2021
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch
October 11, 2021
Nutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)
October 3, 2021
Nutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital Market
September 30, 2021
Nutriband Inc. Files Pro Forma Financials Consolidating the Recent Acquisition of Pocono Coated Products Transdermal and Topical Business and Active Intelligence
January 12, 2021